Combination Study of Guadecitabine/ASTX727 and Pembrolizumab
Clinical trial NCT02998567 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02998567
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-26
- Primary completion
- 2026-09-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.